市場調查報告書
商品編碼
1451213
2024-2032 年按產品、適應症(慢性阻塞性肺病、氣喘、睡眠呼吸中止症、傳染病等)、最終用戶和地區分類的呼吸護理設備市場報告Respiratory Care Devices Market Report by Product, Indication (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease, and Others), End-User, and Region 2024-2032 |
2023年,全球呼吸照護設備市場規模達到219億美元。展望未來, IMARC Group預計到2032年市場規模將達到424億美元,2024-2032年複合年成長率(CAGR)為7.4%。
呼吸照護設備是指用於診斷、治療、評估和照護肺部疾病患者的醫療設備。霧化器、吸入器、氣道正壓通氣 (PAP) 裝置、肺活量計、加濕器等是一些最常用的呼吸護理裝置。這些設備主要執行診斷、治療和監測功能。它們透過向肺部提供充足的氧氣並防止呼吸過程中出現任何阻塞來幫助確保呼吸過程順利進行。
慢性阻塞性肺病(COPD)、氣喘和結核病等呼吸系統疾病的盛行率不斷上升,是推動市場成長的關鍵因素。久坐的生活方式和緊張的生活習慣,加上吸煙者數量和飲酒率的增加,導致肺癌和其他嚴重呼吸道疾病的發病率上升。此外,早產數量的增加以及老年人口的增加也影響了對呼吸照護設備的需求。早產兒和老年人的免疫系統往往較弱,需要各種呼吸支持裝置來促進人工呼吸和預防呼吸系統疾病,包括新生兒呼吸窘迫症候群(RDS)。其他因素,例如醫療保健支出的增加和微型設備的開發,預計將進一步推動市場。政府和非政府組織 (NGO) 為向所有人提供優質醫療保健設施所做的重大努力,以及開發新的和改善現有的醫療保健基礎設施,也為市場創造了積極的前景。
The global respiratory care devices market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory care devices market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product, indication and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Ventilators
Nebulizers
Humidifiers
Inhalers
Other
Monitoring Devices
Pulse Oximeters
Gas Analyzers
Others
Diagnostic Devices
Spirometers
Polysomnography Devices
Peak Flow Meters
Others
Consumables and Accessories
Masks
Disposable Resuscitators
Breathing Circuits
Tracheostomy Tubes
Nasal Cannulas
Others
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Sleep Apnea
Infectious Disease
Others
Hospitals
Home Care Settings
Ambulatory Care Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Dragerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., Rotech Healthcare Inc., etc.